At Regenesis, every IV and injectable treatment is medically guided
Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidence
At therapeutically and research-relevant doses, MC4R is the primary pharmacologically active receptor both because it has the highest CNS expression density in regions governing sexual behaviour and because MC1R-mediated pigmentation effects (the basis of the tanning response to MT-II) are substantially attenuated in PT-141s cyclic structure
Recently, belimumab and anifrolumab have shown clinical benefits by neutralizing the B cell activating factor to reduce abnormal B cell survival, and by blocking the type I interferon receptor to inhibit interferon-driven inflammation, improving disease activity, reducing flares, and lowering steroid use (84)
Dubbed the master antioxidant by many, the powerhouse is renowned for its powerful and proven results